Literature DB >> 32006643

Increase in oxidized low-density lipoprotein level according to hyperglycemia in patients with cardiovascular disease: A study by structure equation modeling.

Takayuki Yamada1, Kazuo Ogawa2, Toshikazu D Tanaka1, Tomohisa Nagoshi1, Kosuke Minai1, Takayuki Ogawa1, Makoto Kawai1, Michihiro Yoshimura1.   

Abstract

AIMS: Malondialdehyde-modified low-density lipoprotein (MDA-LDL) level has been reported to be strongly associated with the pathogenesis of cardiovascular diseases. We focused on diabetic status and investigated its possible contribution to MDA-LDL level.
METHODS: The study sample consisted of 2705 patients who were admitted to our hospital and underwent cardiac catheterization. Blood samples were obtained to measure the levels of fasting blood sugar (FBS), hemoglobin A1c (HbA1c), insulin, LDL, MDA-LDL and others. Body mass index (BMI) was also used in constructing structural equation modeling and Bayesian estimation.
RESULTS: To explore the factors theoretically associated with MDA-LDL level, we performed structural equation modeling. We generated a path model that revealed that BMI, LDL level and FBS were significantly associated with MDA-LDL level (P < 0.001 for each factor), whereas insulin level and HbA1c level were not significantly associated (P = NS for both factors). Noted above was clearly demonstrated on the image of 2-D contour line by Bayesian structure equation modeling.
CONCLUSIONS: This study clearly showed that hyperglycemia affects MDA-LDL level. An interaction between diabetes and dyslipidemia was shown in terms of activation of lipid oxidation.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dyslipidemia; Hyperglycemia; MDA-LDL

Mesh:

Substances:

Year:  2020        PMID: 32006643     DOI: 10.1016/j.diabres.2020.108036

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  2 in total

1.  Close linkage between blood total ketone body levels and B-type natriuretic peptide levels in patients with cardiovascular disorders.

Authors:  Yusuke Kashiwagi; Tomohisa Nagoshi; Yasunori Inoue; Yoshiro Tanaka; Hirotake Takahashi; Yuhei Oi; Haruka Kimura; Kousuke Minai; Michihiro Yoshimura
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

Review 2.  Metabolic Disruption by Naturally Occurring Mycotoxins in Circulation: A Focus on Vascular and Bone Homeostasis Dysfunction.

Authors:  Amir Mohammad Malvandi; Sara Shahba; Jalil Mehrzad; Giovanni Lombardi
Journal:  Front Nutr       Date:  2022-06-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.